Physician profile
Seth Koster
NPI 1588906077
$1,325.78
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $76.83 · 2021: $231 · 2022: $141 · 2023: $617 · 2024: $13.07 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $260.94 | 2021-2025 | Epclusa |
| Glaxosmithkline, LLC. | $177.92 | 2023 | Arexvy |
| Novo Nordisk INC | $170.97 | 2020-2022 | |
| Edwards Lifesciences Corporation | $146.63 | 2023 | Sapien 3 Ultra Resilia |
| Esperion Therapeutics, INC. | $126.65 | 2021 | |
| Allergan, INC. | $115.14 | 2019 | |
| Inspire Medical Systems, INC. | $113.68 | 2023 | Inspire |
| Intuitive Surgical, INC. | $63.07 | 2023-2024 | Da Vinci Surgical System |
| Pfizer INC. | $56.11 | 2022-2023 | |
| Perspectum Diagnostics LTD | $54.75 | 2023 | Livermultiscan |
| Actelion Pharmaceuticals US, INC. | $23.36 | 2019 | |
| Abbott Laboratories | $16.56 | 2023 | Freestyle Libre 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Koster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.